Why Cordlife
Singapore’s first FACT-Netcord and AABB accredited cord blood bank with a successful transplant track record
Cord Lining/Tissue Release Track Record
Total Releases:
8
The table below features the cord lining/tissue releases performed by Cordlife Group Limited and its subsidiaries. As a Group, we have made eight cord linings or tissue releases, all of which have been used successfully in cellular therapy.
| NO | RELEASE | MEDICAL CONDITION | RECIPIENT'S RELATIONSHIP | STORAGE TIME (in months) | TREATMENT FACILITY |
|---|---|---|---|---|---|
| 1 | 2015 | Cerebral Palsy | Self | 7.1 | RS Mayapada |
| 2 | 2016 | Cerebral Palsy | Sibling | 12.3 | RS Harapan Kita / RS Mayapada |
| 3 | 2017 | Dementia | Grandfather | 3.6 | RS Medistra |
| 4 | 2017 | Spina Bifida | Sibling | 10.8 | RS PON |
| 5 | 2018 | Cerebral Palsy | Sibling | 7.7 | RS Cipto Mangunkusumo |
| 6 | 2018 | Diabetes | Grandfather | 16.7 | RS Medistra |
| 7 | 2019 | Kidney Disease | Grandfather | 26.8 | Vinski Regenerative Centre |
| 8 | 2021 | Stroke | Grandfather | 5.5 | Vinski Regenerative Centre |
This list shows the cord lining/tissue released by Cordlife and its subsidiaries to support the treatment of various diseases. This should not be used as a reference for the list of treatable diseases by cord lining/tissue stem cells. In addition, banking your baby’s cord lining/tissue does not guarantee that the stem cells will provide a cure or be applicable in every situation. Use is ultimately determined by the treating physician.
Some releases may be for the same client but released at different times.
DCR No. 4232, Version B, October 2021